Government news, all in one place

Medicines and Healthcare products Regulatory Agency

Medicines and Healthcare products Regulatory Agency

The Medicines and Healthcare products Regulatory Agency (MHRA) is a UK government agency responsible for ensuring that medicines, medical devices, and blood components for transfusion meet applicable standards of safety, quality, and efficacy.

Communication Overview

Total releases

Number of press releases published by this department during the last 12 months, based on publicly available announcements.
140

Avg per month

Average number of press releases published per calendar month over the last 12 months. This smooths short-term fluctuations in publishing activity.
11.7

Avg word count

Average length of published press releases, measured in words. Calculated only for months where content was published.
863

Avg readability

Average Flesch Reading Ease score across all published press releases. Higher values indicate plainer English. Scores are indicative only and vary by subject matter.
26

Friday PM releases

Percentage of press releases published after 3pm on Fridays, relative to the department’s total output during the period.
3.6%

Single-release items

Estimated proportion of announcements published once, without a closely related follow-up release during the same period. This is based on similarity of titles and timing.
100%
Metrics are descriptive only and indicate publication patterns rather than intent or impact.

Releases per month

Based on publicly published press releases (last 12 months)

787 articles

Showing 1-30

Isotretinoin prescribing requirements updated with revised risk minimisation measures

Isotretinoin prescribing requirements updated with revised risk minimisation measures

Thursday, 22 January 2026

The updated safety measures will strengthen the MHRA’s ability to monitor safe prescribing while supporting patient access to treatment across all age...

Read More → news_story
MHRA scientists contribute to international study on novel oral polio vaccine stability 

MHRA scientists contribute to international study on novel oral polio vaccine stability 

Monday, 19 January 2026

Study confirms vaccine being used in global efforts to achieve and sustain polio eradication is successfully interrupting polio outbreaks whilst minim...

Read More → press_release
MHRA statement on new review of paracetamol safety during pregnancy

MHRA statement on new review of paracetamol safety during pregnancy

Saturday, 17 January 2026

Paracetamol should be taken as directed in the patient information leaflet....

Read More → news_story
Medicines regulator approves up to 7.2mg dose of semaglutide?(Wegovy) for patients with obesity only

Medicines regulator approves up to 7.2mg dose of semaglutide?(Wegovy) for patients with obesity only

Friday, 16 January 2026

The Medicines and Healthcare products Regulatory Agency (MHRA) approved a maximum dose of up to 7.2mg per week of semaglutide (Wegovy) on 6 January 20...

Read More → news_story
Patients to benefit sooner as UK boosts clinical trials attractiveness with faster assessments and agile regulation 

Patients to benefit sooner as UK boosts clinical trials attractiveness with faster assessments and agile regulation 

Tuesday, 13 January 2026

The MHRA is now setting out the next phase of reforms for 2026, aimed at helping patients access new cutting-edge treatments more quickly and boosting...

Read More → press_release
MHRA strengthening dependency and addiction warnings on medicines used to treat pain, anxiety, and insomnia

MHRA strengthening dependency and addiction warnings on medicines used to treat pain, anxiety, and insomnia

Thursday, 08 January 2026

Updated product information and packaging will help patients better understand the risks of dependency, addiction, and withdrawal with these medicines...

Read More → press_release
Professor Sir Aziz Sheikh: Towards next generation pharmacovigilance capabilities for the UK

Professor Sir Aziz Sheikh: Towards next generation pharmacovigilance capabilities for the UK

Thursday, 08 January 2026

As medicines and medical technologies become more complex, there are exciting opportunities to further strengthen our safety monitoring systems....

Read More → news_story
Nirogacestat hydrobromide approved to treat desmoid tumours 

Nirogacestat hydrobromide approved to treat desmoid tumours 

Wednesday, 07 January 2026

As with any medicine, the MHRA will keep the safety and effectiveness of Nirogacestat hydrobromide under close review. ...

Read More → press_release
MHRA welcomes Professor Jacob George as he starts Chief Medical and Scientific Officer role

MHRA welcomes Professor Jacob George as he starts Chief Medical and Scientific Officer role

Monday, 05 January 2026

In this new role, Professor George will lead the Agency’s science strategy and will oversee the MHRA’s scientific, research and innovation activities....

Read More → press_release
MHRA approves zapomeran (Kostaive) mRNA COVID 19 vaccine

MHRA approves zapomeran (Kostaive) mRNA COVID 19 vaccine

Friday, 02 January 2026

As with any medicine, the MHRA will keep the safety and effectiveness of zapomeran under close review....

Read More → press_release
MHRA urges public to avoid illegal online weight loss medicines this New Year

MHRA urges public to avoid illegal online weight loss medicines this New Year

Monday, 29 December 2025

As many people consider lifestyle changes at the start of the year, the Medicines and Healthcare products Regulatory Agency (MHRA) is urging the publi...

Read More → press_release
Keep the warmth, lose the risk: MHRA and National Fire Chiefs Council issue winter emollient safety warning

Keep the warmth, lose the risk: MHRA and National Fire Chiefs Council issue winter emollient safety warning

Wednesday, 24 December 2025

As colder weather arrives, the Medicines and Healthcare products Regulatory Agency (MHRA) and the National Fire Chiefs Council (NFCC) are urging the p...

Read More → press_release
How medicines affect gut bacteria could inform safer, more effective use

How medicines affect gut bacteria could inform safer, more effective use

Tuesday, 23 December 2025

Understanding gut microbiome interactions with medicines could help explain differences in how people respond to treatment and build on existing medic...

Read More → press_release
Healthcare regulator suggests simple winter wellness choices to keep you safe this cough and cold season

Healthcare regulator suggests simple winter wellness choices to keep you safe this cough and cold season

Monday, 22 December 2025

As the cold weather sets in and coughs and colds become more common, the MHRA is reminding people that small, everyday choices can make a big differen...

Read More → press_release
MHRA approves lenacapavir for the prevention of sexually transmitted HIV 1 infection

MHRA approves lenacapavir for the prevention of sexually transmitted HIV 1 infection

Friday, 19 December 2025

As with any medicine, the MHRA will keep the safety and effectiveness of lenacapavir under close review....

Read More → press_release
MHRA seeks input on AI regulation at ‘pivotal moment’ for healthcare

MHRA seeks input on AI regulation at ‘pivotal moment’ for healthcare

Thursday, 18 December 2025

National Commission is seeking evidence to shape regulation of AI in healthcare and support the UK’s ambition for a world-leading, AI-enabled NHS ...

Read More → press_release
MHRA updates guidance on the Health Institution Exemption to support safe use of medical devices

MHRA updates guidance on the Health Institution Exemption to support safe use of medical devices

Wednesday, 17 December 2025

Updated MHRA guidance will help health institutions, such as NHS Trusts and Boards, safely design and make general medical devices for patients....

Read More → news_story
Professor Bola Owolabi CBE: Creating the Climate for Health Equity

Professor Bola Owolabi CBE: Creating the Climate for Health Equity

Tuesday, 16 December 2025

Exploring the MHRA's transformational impact on access, experience, and outcomes....

Read More → news_story
UK approves the first twice yearly biological medicine for asthma and severe chronic rhinosinusitis with nasal polyps

UK approves the first twice yearly biological medicine for asthma and severe chronic rhinosinusitis with nasal polyps

Monday, 15 December 2025

As with any medicine, the MHRA will keep the safety and effectiveness of depemokimab under close review....

Read More → press_release
European first as MHRA approves over the counter allergy treatment for adolescents aged 12 and over

European first as MHRA approves over the counter allergy treatment for adolescents aged 12 and over

Monday, 15 December 2025

As with any medicine, the MHRA will keep the safety and effectiveness of fluticasone propionate under close review.?...

Read More → press_release
Festive foods and your medicines: MHRA shares advice to help you stay safe this winter

Festive foods and your medicines: MHRA shares advice to help you stay safe this winter

Monday, 15 December 2025

This holiday season, the MHRA is reminding people that some common festive foods can interact with medicines, altering how well they work or increasin...

Read More → press_release
MHRA welcomes Professor Jonathan?Benger CBE as new CEO of NICE

MHRA welcomes Professor Jonathan?Benger CBE as new CEO of NICE

Monday, 15 December 2025

Professor Benger’s leadership comes at a pivotal time as the MHRA and NICE deepen collaboration...

Read More → news_story
UK and Singapore launch a regulatory innovation corridor to speed up access to breakthrough health technologies

UK and Singapore launch a regulatory innovation corridor to speed up access to breakthrough health technologies

Friday, 12 December 2025

Patients in the UK and Singapore could gain faster access to cutting-edge healthcare innovations under a new partnership bringing two globally respect...

Read More → press_release
MHRA Chair welcomes re appointment of three non executive directors

MHRA Chair welcomes re appointment of three non executive directors

Thursday, 11 December 2025

Professor Anthony Harnden has congratulated the trio of Agency board members on the extension of their appointments....

Read More → news_story
Mirdametinib approved to treat plexiform neurofibromas in children, adolescents, and adults with neurofibromatosis type 1

Mirdametinib approved to treat plexiform neurofibromas in children, adolescents, and adults with neurofibromatosis type 1

Thursday, 11 December 2025

As with any medicine, the MHRA will keep the safety and effectiveness of mirdametinib under close review.?...

Read More → press_release
Strengthening collaboration between the MHRA and the Department of Health Northern Ireland

Strengthening collaboration between the MHRA and the Department of Health Northern Ireland

Tuesday, 09 December 2025

The MHRA and Northern Ireland partners are working together to support innovation, enhance patient safety and ensure people in Northern Ireland benefi...

Read More → news_story
Five festive mistakes you didn’t know you were making: 

MHRA urges the public to be merry, not risky – don’t mix medicines with alcohol

Five festive mistakes you didn’t know you were making: MHRA urges the public to be merry, not risky – don’t mix medicines with alcohol

Monday, 08 December 2025

This holiday season, the MHRA is highlighting one of the most overlooked winter health risks: combining medicines with alcohol....

Read More → press_release
Hepatitis B vaccines for babies

Hepatitis B vaccines for babies

Saturday, 06 December 2025

All babies in the UK get the hepatitis B vaccine. It has a well-established safety record and ensures long-term protection against the virus. ...

Read More → news_story
Chris Kessler: How access to innovative rare therapies can transform the lives of children like Charlie

Chris Kessler: How access to innovative rare therapies can transform the lives of children like Charlie

Wednesday, 03 December 2025

A story of hope, medical innovation, and the impact of effective regulation on access to treatment....

Read More → news_story
MHRA approves tisotumab vedotin for the treatment of cervical cancer

MHRA approves tisotumab vedotin for the treatment of cervical cancer

Tuesday, 02 December 2025

As with all licensed medicines, we will continue to monitor its safety closely as it becomes more widely used...

Read More → press_release

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: